MUMBAI, India, Aug. 22 -- Intellectual Property India has published a patent application (202517043385 A) filed by Garuda Therapeutics, Inc., Cambridge, U.S.A., on May 5, for 'b cell lineages derived from pluripotent cells.'
Inventor(s) include Shah, Dhvanit.
The application for the patent was published on Aug. 22, under issue no. 34/2025.
According to the abstract released by the Intellectual Property India: "The present disclosure provides for efficient ex vivo processes for generating B cell lineages from human induced pluripotent stem cells (iPSCs). Cells generated according to the disclosure in various embodiments are functional and/or more closely resemble the corresponding lineage isolated from peripheral blood or lymphoid organs. The present invention in some aspects provides isolated cells and cell compositions produced by the methods disclosed herein, as well as methods for cell therapy."
The patent application was internationally filed on Oct. 05, 2023, under International application No.PCT/US2023/076111.
Disclaimer: Curated by HT Syndication.
